House committee advances bills on advanced manufacturing, opioids and more
Regulatory NewsMichael Mezher
APIsBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)North AmericaPharmaceuticalsRegulatory Intelligence/Policy